Mirion Technologies MIR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical Segment | $72.1M-12.6% | $82.5M+5.1% | $78.5M-3.3% | $81.2M+18.4% | $68.6M-19.9% | |
| Nuclear & Safety | $185.5M-4.8% | $194.9M+34.8% | $144.6M+2.0% | $141.7M+6.2% | $133.4M-20.9% | |
| Segment Income From Operations by Business | ||||||
| Medical Segment | $7.8M-58.1% | $18.6M+73.8% | $10.7M-1.8% | $10.9M+62.7% | $6.7M-43.7% | |
| Nuclear & Safety | $20.9M-46.5% | $39.1M+83.6% | $21.3M+12.1% | $19M-12.4% | $21.7M-34.4% | |
| Adjusted Income Loss From Operations by Business | ||||||
| Medical Segment | -$25.4M+6.3% | -$27.1M+2.5% | -$27.8M+6.1% | -$29.6M-20.8% | -$24.5M+18.6% | |
| Nuclear & Safety | -$99.5M+0.5% | -$100M-29.9% | -$77M+1.0% | -$77.8M-12.4% | -$69.2M+22.7% | |
| Other segment items by Business | ||||||
| Medical Segment | $38.9M+5.7% | $36.8M-8.0% | $40M-1.7% | $40.7M+8.8% | $37.4M-14.2% | |
| Nuclear & Safety | $65.1M+16.7% | $55.8M+20.5% | $46.3M+3.1% | $44.9M+5.6% | $42.5M-7.8% | |
| D&A by Business | ||||||
| Medical Segment | $16.2M0.0% | $16.2M-2.4% | $16.6M+1.8% | $16.3M-0.6% | $16.4M-5.2% | |
| Nuclear & Safety | $24.3M+25.9% | $19.3M+6.6% | $18.1M+4.6% | $17.3M+1.8% | $17M0.0% | |
| CapEx by Business | ||||||
| Medical Segment | $3.7M-40.3% | $6.2M+12.7% | $5.5M+44.7% | $3.8M-19.1% | $4.7M-14.5% | |
| Nuclear & Safety | $4.8M-11.1% | $5.4M+8.0% | $5M+4.2% | $4.8M+37.1% | $3.5M-46.2% | |
| Translation adjustment by Business | ||||||
| Medical Segment | $0— | $0— | $0— | $0— | $0— | |
| Nuclear & Safety | -$9.6M-580% | $2M+567% | $300K-99.0% | $31.1M+132% | $13.4M+344% | |
| Goodwill by Business | ||||||
| Medical Segment | $634M0.0% | $634M0.0% | $634M0.0% | $634M0.0% | $634M0.0% | |
| Nuclear & Safety | $1.23B-1.0% | $1.24B+2,123% | $55.7M-93.3% | $836.7M+3.9% | $805.6M+1.7% | |
| Measurement period adjustment by Business | ||||||
| Medical Segment | $0— | —— | —— | —— | —— | |
| Nuclear & Safety | -$2.4M— | —— | —— | —— | —— | |
| Total revenues by Product | ||||||
| Cancer care | $55.3M-13.5% | $63.9M+3.1% | $62M-0.3% | $62.2M+22.0% | $51M-22.7% | |
| Labs and research | $28.3M-16.8% | $34M0.0% | $34M+24.1% | $27.4M+2.2% | $26.8M-26.8% | |
| Nuclear power | $125.8M— | —— | —— | —— | $84.1M— | |
| Other | $16.8M-51.2% | $34.4M+19.4% | $28.8M-10.6% | $32.2M+83.0% | $17.6M-48.7% | |
| Total cost of revenues by Product | ||||||
| Product | $112.9M+0.2% | $112.7M+25.9% | $89.5M-3.5% | $92.7M+13.5% | $81.7M-19.7% | |
| Service | $25.6M-12.3% | $29.2M+0.3% | $29.1M+5.1% | $27.7M+14.5% | $24.2M-20.1% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $4.7M+6.8% | $4.4M+37.5% | $3.2M+45.5% | $2.2M-62.1% | $5.8M+93.3% | |
| Europe | $77.9M-25.6% | $104.7M+38.3% | $75.7M-7.5% | $81.8M+24.9% | $65.5M-31.4% | |
| North America | $175M+4.0% | $168.3M+16.7% | $144.2M+3.8% | $138.9M+6.3% | $130.7M-16.1% | |
| Property, plant, and equipment, net by Geography | ||||||
| Asia Pacific | $100K0.0% | $100K0.0% | $100K0.0% | $100K0.0% | $100K0.0% | |
| Europe | $58.6M-4.6% | $61.4M+0.7% | $61M+0.2% | $60.9M+8.2% | $56.3M+2.9% | |
| North America | $93.9M+0.5% | $93.4M+1.3% | $92.2M+0.1% | $92.1M+0.3% | $91.8M+0.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical Segment and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.